Science News

EPALINGES, Switzerland--(BUSINESS WIRE)--Novigenix AI, a leader in AI-driven healthcare solutions, today announced the presentation of new data at the American Association for Cancer Research (AACR) 2026 Annual Meeting demonstrating, for the first time in a human clinical setting, the dynamic role of the immune system in response to radioligand therapy in patients with metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NET).1 The study, conducted in collaboration with RadioMedix, Inc....

MADISON, Wis.--(BUSINESS WIRE)--Promega will distribute NimaGen's IDseek® MPS library prep kits for forensic casework through a new distribution agreement with NimaGen....

NEWTON, Mass.--(BUSINESS WIRE)--4D Path Announces Collaboration with Daiichi Sankyo to Advance AI-Driven Predictive Biomarkers for an Antibody Drug Conjugate Program...

LEXINGTON, Mass.--(BUSINESS WIRE)--Valo Health, Inc. (“Valo”), a pioneer in the use of human data and AI to accelerate drug discovery and development, today announced the appointment of Chris Anagnostopoulos, PhD, C.Stat, to the newly created position of Chief Causal AI Officer. In this role, Dr. Anagnostopoulos will lead the advancement of Valo’s human causal biology platform, translating large-scale, real‑world human data into causal insights that inform drug discovery. Valo aims to improve c...

JACKSONVILLE, Fla.--(BUSINESS WIRE)--Redwire Corporation (NYSE: RDW), a global leader in space and defense technology solutions, today announced it has received awards totaling over $20M in Purchase Orders (POs) in Q1 FY2026 supporting the Navy and Marine Corps Small Tactical Unmanned Aircraft Systems Program Office (PMA263) Family of Small UAS (FoSUAS) Team. This award encompasses the Marine Corps’ first acquisition of Redwire’s Advanced Navigation version of the Stalker Block 30 uncrewed aeri...

LONDON & NEW YORK--(BUSINESS WIRE)--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today an invitation for U.S. based organizations to apply for a grant to create training content for healthcare providers to deliver investigational COMP360 psilocybin treatment, if approved. Many high-quality training organizations already exist and have trained thousands of HCPs in core and psilocybin...

FRAMINGHAM, Mass.--(BUSINESS WIRE)--Alzheon, Inc., a clinical-stage biopharmaceutical company developing investigational therapies for patients with Alzheimer’s disease (AD) and related neurodegenerative disorders, today announced it will present new clinical, safety, imaging, and biomarker findings, as well as brain edema (ARIA-E) and brain microhemorrhage (ARIA-H) for its lead investigational therapy, valiltramiprosate/ALZ-801, at the American Academy of Neurology (AAN) Annual Meeting in Chic...

OXFORD, England--(BUSINESS WIRE)--ProImmune, Ltd., a global leader in immunological reagents and services, today announced a collaboration with The University of Texas Medical Branch (UTMB) Galveston National Laboratory (GNL), a high-containment, infectious disease research facility, to develop innovative tools for studying high-consequence emerging and endemic infectious diseases. Under the agreement, ProImmune’s Ankyrons will be evaluated as molecular tools to enable precise detection, locali...

CAMBRIDGE, England--(BUSINESS WIRE)--ELRIG announces Drug Discovery USA 2026. The inaugural event takes place at Pfizer in Cambridge, MA from 16–17 June and is free to attend....

LONDON--(BUSINESS WIRE)--Clean Food Group, a leading UK biotech manufacturer pioneering sustainable oils and fats through fermentation, is pleased to confirm a £4.5 million investment led by Clean Growth Fund and New Agrarian, two specialist investors dedicated to fostering sustainable growth in food technology. CFG has also successfully secured a £700,000 non-dilutive grant from Innovate UK which further improves the Company’s financial position. Following the transformational acquisition of C...